FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • April 12th, 2019 • NextCure, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of [·], between NEXTCURE, INC., a Delaware corporation (the “Company”), and [NAME] (“Indemnitee”).
LEASE AGREEMENTLease Agreement • April 12th, 2019 • NextCure, Inc. • Pharmaceutical preparations • Delaware
THIS LEASE AGREEMENT (“this Lease”) is made as of this 30 day of January, 2019, between ARE-8000/9000/10000 VIRGINIA MANOR, LLC, a Delaware limited liability company (“Landlord”), and NEXTCURE, INC., a Delaware corporation (“Tenant”).
YALE UNIVERSITY CORPORATE SPONSORED RESEARCH AGREEMENTCorporate Sponsored Research Agreement • April 12th, 2019 • NextCure, Inc. • Pharmaceutical preparations • New York
This CORPORATE SPONSORED RESEARCH AGREEMENT (this “AGREEMENT”) is effective as of December 29, 2015 (the “EFFECTIVE DATE”), by and between YALE UNIVERSITY, a non-profit corporation organized and existing under and by virtue of a special charter granted by the general assembly of the Colony and State of Connecticut (the “UNIVERSITY”), and NEXTCURE, INC., a Delaware corporation (the “SPONSOR”). UNIVERSITY and SPONSOR are each referred to herein individually, as a “party” and, collectively, as the “parties.”
NEXTCURE, INC.Stock Option Agreement • April 12th, 2019 • NextCure, Inc. • Pharmaceutical preparations
NextCure, Inc., a Delaware corporation (the “Company”), hereby grants an option (the “Option”) to purchase shares of its common stock, par value $0.001 (the “Stock”), to the individual named below as Grantee. The terms and conditions of the Option are set forth in this cover sheet and in the attachment (collectively, the “Agreement”) and in the Company’s 2015 Omnibus Incentive Plan (as it may be amended from time to time, the “Plan”).
RESEARCH AND DEVELOPMENT COLLABORATION AGREEMENT between NEXTCURE, INC. and ELI LILLY AND COMPANYResearch and Development Collaboration Agreement • April 12th, 2019 • NextCure, Inc. • Pharmaceutical preparations • New York
This RESEARCH AND DEVELOPMENT COLLABORATION AGREEMENT (this “Agreement”) is effective as of November 2, 2018 (the “Effective Date”), and is entered into by and between:
LICENSE AGREEMENT BY AND BETWEEN YALE UNIVERSITY AND NEXTCURE, INC.License Agreement • April 12th, 2019 • NextCure, Inc. • Pharmaceutical preparations • New York
This License Agreement (the “AGREEMENT”) by and between Yale University, a nonprofit corporation organized and existing under and by virtue of a charter granted by the general assembly of the Colony and State of Connecticut (“YALE”), and NextCure, Inc., a corporation organized and existing under the laws of the State of Delaware (“LICENSEE”), is effective as of December 29, 2015 (“EFFECTIVE DATE”). YALE and LICENSEE are each referred to herein, individually, as a “party” and, collectively, as the “parties.”
AMENDED AND RESTATED SUBLEASE AGREEMENTSublease Agreement • April 12th, 2019 • NextCure, Inc. • Pharmaceutical preparations • Maryland
This AMENDED AND RESTATED SUBLEASE AGREEMENT (the “Sublease”) is made as of this 15th day of March, 2019 (the “Effective Date”), by and between LUPIN, INC., a Delaware corporation (“Sublandlord”) and NEXTCURE, INC., a Delaware corporation (“Subtenant”).
